CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

AAV9 capsid enrichment by optimization of anion exchange chromatography

AAV9 capsid enrichment by optimization of anion exchange chromatography

Angela Andaluz, Joshua Orchard
01 November 2024
FastFacts
Redefining the economics of upstream mAb and viral vector bioprocessing: how process intensification boosts productivity

Redefining the economics of upstream mAb and viral vector bioprocessing: how process intensification boosts productivity

Rachel Legmann
30 October 2024
FastFacts
High-throughput process development and scale-up to 2,000 L for rAAV production to address unmet patient needs

High-throughput process development and scale-up to 2,000 L for rAAV production to address unmet patient needs

Pouria Motevalian
15 October 2024
FastFacts
Demystifying AAV affinity capture: mapping AAV-affinity ligand footprints with cryo-electron microscopy

Demystifying AAV affinity capture: mapping AAV-affinity ligand footprints with cryo-electron microscopy

Nathaniel Clark
26 September 2024
FastFacts
 Navigating variability and scalability challenges in AAV production

Navigating variability and scalability challenges in AAV production

Rafal Garus
05 September 2024
FastFacts
AAV capture purification scaling from bench to clinical manufacturing

AAV capture purification scaling from bench to clinical manufacturing

Kathleen Mihlbachler
27 August 2024
FastFacts
Get your non-viral T cell engineering process ready for clinical manufacturing

Get your non-viral T cell engineering process ready for clinical manufacturing

Melanie Rietenbach
05 June 2024
FastFacts
Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration

Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration

Béla Brühlmann, Sven Göbel
23 May 2024
FastFacts
Accelerate time to clinic for advanced therapies with a platform approach

Accelerate time to clinic for advanced therapies with a platform approach

John Lee, Cédrick Rousseaux, Dana Cipriano
16 April 2024
FastFacts
Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Johanna Viiliäinen
19 March 2024
FastFacts
Is bigger better? Modeling AAV production to find optimization opportunities

Is bigger better? Modeling AAV production to find optimization opportunities

Andrea Vervoort
05 January 2024
FastFacts
 The evolution of gene therapy manufacturing

The evolution of gene therapy manufacturing

Rachel Legmann
21 December 2023
FastFacts
Streamlining nucleic acid extraction for biotherapy manufacturing: manual and automated solutions for success

Streamlining nucleic acid extraction for biotherapy manufacturing: manual and automated solutions for success

Suzy Brown
30 November 2023
FastFacts
HEK293 suspension culture in stirred 3D-systems for gene therapy development

HEK293 suspension culture in stirred 3D-systems for gene therapy development

Jorge Escobar
14 November 2023
FastFacts
Analyzing lentivirus particles using dPCR techniques

Analyzing lentivirus particles using dPCR techniques

Samyuktha Shankar
21 September 2023
FastFacts
Technology transfer process excellence with an AAV comparability study

Technology transfer process excellence with an AAV comparability study

Isabel Guerrero Montero
02 September 2023
FastFacts
Addressing purification challenges:  biological pipeline diversity and smaller manufacturing scales

Addressing purification challenges: biological pipeline diversity and smaller manufacturing scales

Sushma Nayak Teichert
12 July 2023
FastFacts
An optimized & streamlined approach for upstream & downstream lentiviral production

An optimized & streamlined approach for upstream & downstream lentiviral production

Gregory Piscitello, Paul Turiano
11 July 2023
FastFacts
Efficient, scalable purification of VSV-G lentivirus by novel affinity chromatography

Efficient, scalable purification of VSV-G lentivirus by novel affinity chromatography

Frank Detmers
07 June 2023
FastFacts
A large-scale lentivirus manufacturing platform to accelerate time to clinic

A large-scale lentivirus manufacturing platform to accelerate time to clinic

Brian Mullan
03 June 2023
FastFacts
Designing viral clearance studies for CGT products according to ICH Q5A (R2): part 2

Designing viral clearance studies for CGT products according to ICH Q5A (R2): part 2

Tareq Jaber
19 May 2023
FastFacts